Literature DB >> 13219376

Aldosterone in urine of normal man and of patients with oedema; its increased recovery after hydrolysis with acid and with beta-glucuronidase.

B J AXELRAD, J E CATES, B B JOHNSON, J A LUETSCHER.   

Abstract

Entities:  

Keywords:  EDEMA/urine in; SODIUM; URINE

Mesh：

Substances：

Year:  1955        PMID： 13219376      PMCID： PMC2060861          DOI： 10.1136/bmj.1.4907.196

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  9 in total

1.  Isolation of crystalline aldosterone from the urine of a nephrotic patient.

Authors:  J A LUETSCHER; R NEHER; A WETTSTEIN
Journal:  Experientia       Date:  1954-11-15

2.  Mechanism of sodium retention in preeclamptic toxemia.

Authors:  E S GORDON; J J CHART; D HAGEDORN; E G SHIPLEY
Journal:  Obstet Gynecol       Date:  1954-07       Impact factor: 7.661

3.  The occurrence of electrocortin in human urine.

Authors:  C L COPE; J GARCIA-LLAURADO
Journal:  Br Med J       Date:  1954-06-05

4.  Excretion of sodium-retaining substances in patients with congestive heart failure.

Authors:  B SINGER; J WENER
Journal:  Am Heart J       Date:  1953-06       Impact factor: 4.749

5.  The hydrolysis of steroid glucuronides with calf spleen glucuronidase.

Authors:  S L COHEN
Journal:  J Biol Chem       Date:  1951-09       Impact factor: 5.157

6.  Methods of paper chromatography of steroids applicable to the study of steroids in mammalian blood and tissues.

Authors:  I E BUSH
Journal:  Biochem J       Date:  1952-01       Impact factor: 3.857

7.  Paper chromatography of steroids. II. Corticosteroids and related compounds.

Authors:  R B BURTON; E H KEUTMANN
Journal:  J Biol Chem       Date:  1951-02       Impact factor: 5.157

8.  Bioassay of adrenal cortical steroids on the basis of electrolyte excretion by rats: effects of 11-desoxy and 11-oxy-steroids.

Authors:  B B JOHNSON
Journal:  Endocrinology       Date:  1954-02       Impact factor: 4.736

9.  Sodium-retaining corticoid in the urine of normal children and adults and of patients with hypoadrenalism or hypopituitarism.

Authors:  J A LUETSCHER; B J AXELRAD
Journal:  J Clin Endocrinol Metab       Date:  1954-09       Impact factor: 5.958
  9 in total
  21 in total

1.  The hepatorenal syndrome: recovery after portacaval shunt.

Authors:  S Ariyan; T Sweeney; M D Kerstein
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

2.  DIURNAL CYCLE OF RENAL HEMODYNAMICS AND EXCRETION OF CHLORIDE AND POTASSIUM IN HYPERTENSIVE SUBJECTS.

Authors:  A I VAGNUCCI; L G WESSON
Journal:  J Clin Invest       Date:  1964-03       Impact factor: 14.808

3.  [ALDOSTERONE METABOLISM AND LIVER DISEASES].

Authors:  M MANN; W SIEGENTHALER
Journal:  Klin Wochenschr       Date:  1964-09-15

4.  The metabolism of aldosterone in normal subjects and in patients with hepatic cirrhosis.

Authors:  W S COPPAGE; D P ISLAND; A E COONER; G W LIDDLE
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

5.  [The effect of amino nucleoside on tubular recovery of sodium ions].

Authors:  H HERKEN; G SENFT
Journal:  Klin Wochenschr       Date:  1961-11-15

6.  Clinical evaluation of hydrochlorothiazide.

Authors:  C W HAVARD; J C FENTON
Journal:  Br Med J       Date:  1959-06-20

7.  Use of spironolactone and hydrochlorothiazide in treatment of oedema.

Authors:  R O FARRELLY; R N HOWIE; J D NORTH
Journal:  Br Med J       Date:  1960-07-30

8.  Adrenocortical steroid metabolism and adrenal cortical function in liver disease.

Authors:  R E PETERSON
Journal:  J Clin Invest       Date:  1960-02       Impact factor: 14.808

9.  Aldosterone excretion in normal subjects depleted of sodium and potassium.

Authors:  B B JOHNSON; A H LIEBERMAN; P J MULROW
Journal:  J Clin Invest       Date:  1957-06       Impact factor: 14.808

10.  A method for the determination of aldosterone, cortisol and corticosterone in biological extracts, particularly applied to human urine.

Authors:  P J AYRES; O GARROD; S A SIMPSON; J F TAIT
Journal:  Biochem J       Date:  1957-04       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.